Description
Science and Mechanism:
FOXO4-DRI is a synthetic peptide developed to target and eliminate senescent cells—cells that have stopped dividing due to age or stress but resist natural cell death. These cells accumulate over time and contribute to aging, inflammation, and tissue dysfunction. FOXO4-DRI works by interfering with the interaction between the FOXO4 protein and the tumor suppressor protein p53. Normally, FOXO4 binds to p53 to prevent cell death in senescent cells. By disrupting this bond, FOXO4-DRI reactivates p53’s ability to induce apoptosis, effectively clearing senescent cells while sparing healthy ones.
Benefits:
The removal of senescent cells through FOXO4-DRI may offer several promising benefits, including reduced systemic inflammation, improved organ function, and increased tissue regeneration. Users and studies suggest potential improvements in skin elasticity, physical energy, cognitive clarity, and resistance to age-related diseases. Overall, FOXO4-DRI represents a novel therapeutic avenue for promoting longevity and healthy aging by targeting one of the root causes of cellular aging.
Reviews
There are no reviews yet.